Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

321 results
Display

Cerebral Venous Thrombosis without Thrombocytopenia after COVID-19 Vaccination

Hwang J, Sohn JH, Lee SH, Lee E, Jeon W, Kim Y

Cerebral venous thrombosis (CVT) is a rare form of cerebrovascular attack and its predisposing factors commonly co-exist. In the coronavirus disease 2019 (COVID-19) era, various side effects of COVID-19 vaccine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review

Choi M, Yu SY, Cheong C, Choe YJ, Choi SH

Purpose: To evaluate the efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines in children aged 5–11 years, a rapid systematic review was conducted on published clinical trials of COVID-19...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Latest Overseas Policy on Coronavirus Disease 2019 Vaccination for Children Aged 5 to 11

Moon J, Choe YJ, Choi YY

In Korea, children aged 5 to 11 have been vaccinated against coronavirus disease 2019 (COVID-19) from March 2022. Due to this age group not being at a high risk of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic

Mir I, Aamir S, Hussain Shah SR, Shahid M, Amin I, Afzal S, Nawaz A, Umer Khan M, Idrees M

The coronavirus disease 2019 (COVID-19) pandemic rapidly spread globally. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, is a positive-sense single-stranded RNA virus with a reported fatality rate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
COVID-19 outbreak response at a nursing hospital in South Korea in the post-vaccination era, including an estimation of the effectiveness of the first shot of the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1-S)

Kim C, Kang G, Kang SG, Lee H

Objectives: We descriptively reviewed a coronavirus disease 2019 (COVID-19) outbreak at a nursing hospital in Gyeonggi Province (South Korea) and assessed the effectiveness of the first dose of the Oxford-AstraZeneca...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine

Park S, You J

Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer

Adin ME, Wu J, Isufi E, Tsui E, Pucar D

Vaccine-related axillary nodal enlargement is a common benign condition that many mRNA vaccine receivers experience. However, a false attribution of axillary swelling to vaccination may result in delay in cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coronavirus disease 2019 (COVID-19) vaccine platforms: how novel platforms can prepare us for future pandemics: a narrative review

Lee JK, Shin OS

More than 2 years after the explosion of the coronavirus disease 2019 (COVID-19) pandemic, extensive efforts have been made to develop safe and efficacious vaccines against infections with severe acute...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID

Lee YJ, Kim SE, Park YE, Chang JY, Song HJ, Kim DH, Yang YJ, Kim BC, Lee JG, Yang HC, Choi M, Myung SJ, The Clinical Practice Guideline Committee of the Korean Association for the Study of the Intestinal Diseases (KASID)

Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, is threatening global health worldwide with unprecedented contagiousness and severity. The best strategy to overcome COVID-19 is a vaccine. Various vaccines...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sleep and vaccine administration time as factors influencing vaccine immunogenicity

Kim ES, Oh CE

The immunogenicity of vaccines is affected by host, external, environmental, and vaccine factors; in addition, sleep or circadian rhythms may also have effects. With the use of vaccines to mitigate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19

Cha HH, Lim SY, Kwon JS, Kim JY, Bae S, Jung J, Kim SH

Background/Aims: Data comparing the antibody responses of different coronavirus disease 2019 (COVID-19) vaccine platforms according to dose with natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced antibody responses are limited. Methods:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Early-Onset Myasthenia Gravis Following COVID-19 Vaccination

Lee MA, Lee C, Park JH, Lee JH

As coronavirus disease 2019 (COVID-19) has spread worldwide, the rate of COVID-19 vaccination uptake is encouraging. Neurological complications associated with COVID-19 vaccines such as stroke, Guillain-Barré syndrome, and Bell’s palsy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health

Lee JH, Song JY, Yi KW, Kim JJ, Hwang KR, Shin JH, Lee JY, Chae HD

Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation in symptomatic patients. In addition, a rare form of thrombosis has been reported in people who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Points to consider for COVID-19 vaccine quality control and national lot release in Republic of Korea: focus on a viral vector platform

Ju JH, Lee N, Kim Sh, Chang S, Yang M, Shin J, Lee E, Sung S, Kim JH, Hong JT, Oh HJ

Due to the global public health crisis caused by the coronavirus disease 2019 (COVID-19) pandemic, the importance of vaccine development has increased. In particular, a rapid supply of vaccines and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Subacute Thyroiditis After Receiving the mRNA COVID-19 Vaccine (Moderna): The First Case Report and Literature Review in Korea

Jhon M, Lee SH, Oh TH, Kang HC

Subacute thyroiditis (SAT) is a painful thyroiditis that often requires steroid therapy. Here, we report the first case of severe SAT in a patient who received the first dose of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination

Gouda W, Albasri A, Alsaqabi F, Al Sabah HY, Alkandari M, Abdelnaby H

Dermatomyositis (DM) is one of the uncommon multi-organ idiopathic inflammatory myopathies that has been reported following the hepatitis B, Influenza, tetanus toxoid, H1N1, and BCG vaccines. However, an association with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Steroid injections in pain management: influence on coronavirus disease 2019 vaccines

Hong SM, Park YW, Choi EJ

The coronavirus disease 2019 (COVID-19) pandemic, which has been rampant since the end of 2019, has evidently affected pain management in clinical practice. Fortunately, a COVID-19 vaccination program is currently in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Measles susceptibility of marriage migrant women in Korea

Kim S, Kim SA, Hong H, Choi SR, Na HY, Shin SU, Park KH, Jung SI, Shin MH, Kweon SS, Kang SJ

International migrants could be considered a risk group susceptible to vaccine-preventable diseases. We conducted a measles seroprevalence study among 419 marriage migrant women living in Sinan-gun and Wando-gun, South Jeolla...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors affecting the Intention to get COVID-19 Vaccine according to Employee’s Health Beliefs

Kim YM, Jung SY, Lee GC, Kim BG

Objectives: The purpose of this study was to investigate the factors in which employee’s health beliefs affect their intention to get COVID-19 vaccines. Methods: The participants of this survey were 237...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Injection Site Reaction Following COVID-19 Vaccination

Park HU, Kim WJ, Kang JW, Ro BI, Cho HK

  • KMID: 2524139
  • Korean J Dermatol.
  • 2021 Dec;59(10):807-808.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr